Neurodevelopmental diagnostic service accreditation framework

Description

NHS Norfolk and Waveney Integrated Care Board were inviting suitably qualified and experienced providers to express their interest in delivering Neurodevelopmental assessment services across NHS Norfolk and Waveney ICB. The contract is for a period of 4 years from 1st November 2024 with the option to extend for up to an additional 4 years (31st October 2032). <br/><br/>There are no finances attached to this Framework as providers will invoice the ICB(s) under the current Right to Choose process. <br/><br/>Tariff is payable on activity undertaken:<br/><br/>Initial Screening and Attention Deficit Hyperactivity Disorder (ADHD) assessment - £1329<br/>Initial Screening and Autism Assessment - £1,749<br/>Initial Screening and Dual Assessment (Autism and ADHD) - £2,130<br/>Medication initiation and titration - £525<br/>Medication review - £150<br/>Patient did not attend fee -50% of tariff rate.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this<br/>contract is subject to the Health Care Services (Provider Selection Regime) Regulations<br/>2023- Direct Award Process B.<br/><br/>This is a new service.